SCHEMBL20098045

SCHEMBL20098045

CC(C)c1ccc2nc(CC(C)c3ccc4nc[nH]c4c3)sc2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SCN4A P35499 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
AKR1B1 P15121 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
QPCT Q16769 6/20 0.35
MMP12 P39900 1/20 0.35
ALOX5 P09917 1/20 0.35
HTR6 P50406 1/20 0.35
PRKCI P41743 1/20 0.35
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
RAD52 P43351 1/20 0.34
QPCTL Q9NXS2 3/20 0.33
KDM5B Q9UGL1 1/20 0.33
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21117234 0.88 NPC1 (0.42) NPC1RAB9ASMN1; SMN2QPCTMMP12
SCHEMBL24420726 0.80 SMN1; SMN2 (0.51) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL19966707 0.80 SMN1; SMN2 (0.51) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL19308856 0.80 NPC1 (0.48) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL19966718 0.78 RAB9A (0.49) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL8013060 0.78 PRKCI (0.53) RAB9ASMN1; SMN2QPCTMMP12PRKCI
SCHEMBL26339590 0.76 NPC1 (0.44) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL19308817 0.75 KDM4E (0.37) RAB9AQPCTMMP12PRKCIHTT
SCHEMBL19966819 0.75 NPC1 (0.43) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1
SCHEMBL19954923 0.73 NPC1 (0.40) NPC1RAB9ASCN4ASMN1; SMN2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957281-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2018-05-01 US disclosed